Antipsychotic treatment, psychoeducation & regular follow up as a public health strategy for schizophrenia: Results from a prospective study
- PMID: 29168458
- PMCID: PMC5719605
- DOI: 10.4103/ijmr.IJMR_838_15
Antipsychotic treatment, psychoeducation & regular follow up as a public health strategy for schizophrenia: Results from a prospective study
Abstract
Background & objectives: In low- and middle-income countries such as India, a feasible public health strategy could be to ensure continuous antipsychotics and psychoeducation for those with schizophrenia. Whether such a strategy favourably influences its course and outcome is not well-studied. The objectives of this study were to examine these issues in a cohort of patients with schizophrenia in a rural south Indian taluk (an administrative block). This cohort was part of a community intervention programme running in the place since the past one decade.
Methods: A total of 201 patients were assessed after an average of four years of follow up. Psychopathology, disability and course of illness were assessed using Positive and Negative Syndrome Scale (PANSS), Indian Disability Evaluation and Assessment Scale (IDEAS) and Psychiatric and Personal History Schedule (PPHS), respectively. Interventions included ensuring continuous antipsychotic treatment and low-intensity psychoeducation.
Results: One hundred and forty two [70.6%; 95% confidence interval (CI): 64.35-76.95] of the 201 patients achieved clinical remission by the end of follow up period (four years); 140 (69.6%; 95% CI: 63.29-76.07) had satisfactory outcome (42.3% best outcome and 27.4% intermediate outcome). There was a significant reduction in the proportion of patients with disability [134/201 (66.7%) at baseline; 55/201 (27.3%) at follow up; PInterpretation & conclusions: Treatment with antipsychotics and psychoeducation can favourably influence the course of schizophrenia and reduce disability in a substantial proportion of patients. Structured psychosocial interventions may be indicated in the significant minority who show suboptimal outcome with this strategy.
Conflict of interest statement
Figures
Comment in
-
Role of primary care in the management of schizophrenia.Indian J Med Res. 2017 Jul;146(1):5-7. doi: 10.4103/ijmr.IJMR_1557_16. Indian J Med Res. 2017. PMID: 29168453 Free PMC article. No abstract available.
Similar articles
-
Work functioning of schizophrenia patients in a rural south Indian community: status at 4-year follow-up.Soc Psychiatry Psychiatr Epidemiol. 2012 Nov;47(11):1865-71. doi: 10.1007/s00127-012-0495-8. Epub 2012 Mar 15. Soc Psychiatry Psychiatr Epidemiol. 2012. PMID: 22419163
-
Prospective comparison of course of disability in antipsychotic-treated and untreated schizophrenia patients.Acta Psychiatr Scand. 2009 Mar;119(3):209-17. doi: 10.1111/j.1600-0447.2008.01299.x. Epub 2008 Nov 24. Acta Psychiatr Scand. 2009. PMID: 19053968
-
[Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].Encephale. 2017 May;43(3):235-240. doi: 10.1016/j.encep.2015.12.028. Epub 2016 Sep 19. Encephale. 2017. PMID: 27658989 French.
-
An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Hum Psychopharmacol. 2011. PMID: 23055416 Review.
-
Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?J Clin Psychiatry. 1999;60 Suppl 5:23-9; discussion 30. J Clin Psychiatry. 1999. PMID: 10192404 Review.
Cited by
-
Cost estimation for the implementation of the Mental Healthcare Act 2017.Indian J Psychiatry. 2019 Apr;61(Suppl 4):S650-S659. doi: 10.4103/psychiatry.IndianJPsychiatry_188_19. Indian J Psychiatry. 2019. PMID: 31040453 Free PMC article. Review.
-
Role of accredited social health activists in treatment of persons with severe mental illness in the community.Indian J Psychiatry. 2022 Jan-Feb;64(1):102-105. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_702_21. Epub 2022 Jan 21. Indian J Psychiatry. 2022. PMID: 35400750 Free PMC article. No abstract available.
-
Impact of incentivizing ASHAs on the outcome of persons with severe mental illness in a rural South Indian community amidst the COVID-19 pandemic.Asian J Psychiatr. 2023 Feb;80:103388. doi: 10.1016/j.ajp.2022.103388. Epub 2022 Dec 5. Asian J Psychiatr. 2023. PMID: 36495728 Free PMC article.
-
Taluk Mental Health Program: The new kid on the block?Indian J Psychiatry. 2019 Nov-Dec;61(6):635-639. doi: 10.4103/psychiatry.IndianJPsychiatry_343_19. Indian J Psychiatry. 2019. PMID: 31896872 Free PMC article.
-
Role of primary care in the management of schizophrenia.Indian J Med Res. 2017 Jul;146(1):5-7. doi: 10.4103/ijmr.IJMR_1557_16. Indian J Med Res. 2017. PMID: 29168453 Free PMC article. No abstract available.
References
-
- Rössler W, Salize HJ, van Os J, Riecher-Rössler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol. 2005;15:399–409. - PubMed
-
- Schizophrenia Working Group. Practice guidelines for the treatment of patients with schizophrenia. 2nd ed. Arlington, VA: American Psychiatric Association; 2004.
-
- Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-analysis. Lancet. 2012;379:2063–71. - PubMed
-
- National Institute for Health and Care Excellence. Psychosis and schizophrenia in adults: Treatment and management. National Clinical Guideline Number 178. London: NICE; 2014.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous